Institution
Tianjin Third Central Hospital
Also known as: 天津市第三中心医院
- 14running trials
- 6closed trials
- 2,529publications (OpenAlex)
Running trials
Not yet recruiting
Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis
Not yet recruiting
Not yet recruiting
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
Recruiting
Recruiting
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Enrolling by invitation
A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver cirrhosis4 recruiting
- Hepatitis B3 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver and biliary tract cancer2 recruiting
- Primary biliary cholangitis2 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Completed
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Completed
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Completed
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality 300000
20 trials
Third Central Hospital of Tianjin
Tianjin, Tianjin Municipality
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Hepatitis B10 works · 5 trials
Institution data: ROR 00911j719 (CC0-1.0)Updated 15 Nov 2026